PTCT Gross Margin

The Gross Margin of PTC Therapeutics, Inc. (PTCT) is 97.28%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

PTCT Gross Margin - Historical Value

Date	Value
2025-12-31	97.28%
2025-03-31	17.94%
2024-12-31	92.89%
2024-03-31	19.46%
2023-12-31	93.02%
2023-03-31	38.48%
2022-12-31	93.60%
2021-12-31	94.00%
2020-12-31	95.04%
2019-12-31	96.06%

PTCT Gross Margin - Peers Comparison

Ticker	Name	Value
CRIS	Curis Inc	99.52%
EDIT	Editas Medicine, Inc.	7775.20%
GILD	Gilead Sciences, Inc.	78.84%
MDGL	Madrigal Pharmaceuticals, Inc.	94.14%
VCEL	Vericel Corporation	74.42%
950160.KQ	Kolon TissueGene Inc	13.28%
950200.KQ	Psomagen Inc	24.48%
ACAD	Acadia Pharmaceuticals Inc.	91.69%
ALLK	Allakos LLC	7775.20%
AMGN	Amgen Inc	70.78%
MYGN	Myriad Genetics, Inc.	69.93%
SRNE	Sorrento Therapeutics Inc	46.82%
SRRK	Scholar Rock Holding Corporation	7775.20%
AGIO	Agios Pharmaceuticals, Inc.	88.26%
VRTX	Vertex Pharmaceuticals Incorporated	86.24%
ZNTL	Zentalis Pharmaceuticals, Inc.	7775.20%
HRTX	Heron Therapeutics Inc	73.31%
MORF	Morphic Holding Inc	7775.20%
TVTX	Travere Therapeutics, Inc.	97.89%
XNCR	Xencor, Inc.	7775.20%
AMRN	Amarin Corporation PLC	56.57%
CBPO	China Biologic Products Holdings Inc	65.68%
MGNX	MacroGenics Inc	75.91%
MRNA	Moderna, Inc.	70.32%
ABBV	AbbVie Inc.	71.62%
ARWR	Arrowhead Pharmaceuticals, Inc.	100.00%
BCRX	BioCryst Pharmaceuticals, Inc.	97.82%
CDMO	Avid Bioservices Inc	5.23%
CHRS	Coherus Oncology Inc	67.24%
INSM	Insmed Incorporated	79.73%
MDXG	MiMedx Group, Inc.	82.56%
ORGO	Organogenesis Holdings Inc.	75.62%
PGEN	Precigen, Inc.	50.20%
REGN	Regeneron Pharmaceuticals, Inc.	86.56%
TWST	Twist Bioscience Corporation	50.72%
950220.KQ	Neoimmunetech Inc	7775.20%
ENTA	Enanta Pharmaceuticals Inc	100.00%